Orange Book product · Generic (ANDA)
RESERPINE
RESERPINE
At a glance
Mar 07, 1985
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Mar 07, 1985
41 yr 11 mo ago
Today
Pharmaceutical detail
Active ingredient
RESERPINE
Strength
0.25MG
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
ANDA 089019
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of RESERPINE
- —SERPASILBrand (NDA)
NDA 009115 · NOVARTIS
- —SANDRILBrand (NDA)
NDA 010012 · LILLY
- —SERPASILBrand (NDA)
NDA 009434 · NOVARTIS
- —HISERPIABrand (NDA)
NDA 009631 · BOWMAN PHARMS
- —RAU-SEDBrand (NDA)
NDA 009357 · BRISTOL MYERS SQUIBB
- —RESERPINEBrand (NDA)
NDA 009663 · BUNDY
- —RESERPINEBrand (NDA)
NDA 009859 · CYCLE
- —RESERPINEBrand (NDA)
NDA 010441 · EVERYLIFE
- —RESERPINEBrand (NDA)
NDA 009627 · IMPAX LABS
- —RESERPINEBrand (NDA)
NDA 011185 · IVAX SUB TEVA PHARMS
- —RESERPINEBrand (NDA)
NDA 009838 · SANDOZ
- —RESERPINEBrand (NDA)
NDA 009667 · VALEANT PHARM INTL
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
